ASCO

Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week, headlining the biotech news flow of the week. In an unexpected M&A move, Morphosys AG (NASDAQ: MOR) announced a deal to...

Biotech stocks could not sustain the uptrend in the holiday-shortened week, even as traders digested COVID-19-related news flow, clinical readouts, ASCO presentations and a few FDA approvals. Arca Biopharma Inc (NASDAQ: ABIO) was the best performing biotech stock of the week, as it rallied in...

After 17 years of clinical work, Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) finally has a marketable product. The Food and Drug Administration approved Qinlock as a fourth-line treatment of gastrointestinal stromal tumors earlier this month.  The kinase inhibitor will be Deciphera...

The American Society of Clinical Oncology annual conference brings together oncology professionals, patient advocates, industry representatives, and major media outlets from across the globe. This year's meeting is is scheduled for May 29-31 and is organized as a virtual event due to the...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs May 13.) AstraZeneca plc (NYSE: AZN) AtriCure Inc. (NASDAQ: ATRC) BioXcel Therapeutics Inc (NASDAQ: BTAI) Catalent Inc (NYSE: CTLT) (announced a...

Mirati Therapeutics Inc (NASDAQ: MRTX)'s shares have been on a tear, advancing over 50 percent since Amgen, Inc. (NASDAQ: AMGN) uploaded an online abstract of its non-small cell lung cancer candidate May 15 to be presented at the ASCO 2019 annual meeting. An analyst at...

Genocea Biosciences (NASDAQ: GNCA) shares rallied higher after the company presented results from lead neoantigen vaccine at the annual meeting of the American Society of Clinical Oncology 2019. Genocea Biosciences develops personalized cancer immunotherapies and announced clinical results from its...

After two successive weeks of losses, biotech stocks slowly clawed back. Multiple conference presentations, independent clinical trial readouts and a few FDA decisions marked the key events in the biotech space. Among the notable biotech movers of the week: BioCryst Pharmaceuticals, Inc. (...

Pharmaceutical company Array BioPharma Inc. (NASDAQ: ARRY) shares dipped more than 3 percent Thursday following comments from a sell-side analyst that investors may have to wait longer for results from Array's BeaconCRC colon cancer study.  The results were expected to be presented at the...

The annual American Society of Clinical Oncology conference kicks off in about two weeks. The annual meeting is scheduled between May 31 and June 4 in Chicago, Illinois, and is promoted as a conference offering education and scientific sessions in all disciplines of oncology. Incidentally, biotech...

Shares of small-cap biotech Iovance Biotherapeutics Inc (NASDAQ: IOVA) were making a strong upward move Thursday on more than 10 times their average volume.  Iovance announced multiple updates in conjunction with online abstracts made available ahead of presentations at the...

The American Society of Clinical Oncology annual meeting started Friday at McCormick Place in Chicago and is set to conclude Tuesday.  With several companies presenting on their respective cancer pipeline drugs, it's no surprise the announcements are moving stocks to varying degrees....

Biotech shares put up a lackadaisical show this week, as reflected by the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB). With earnings season winding down, FDA decisions and data presentations at conferences served as catalysts for stocks in the week. Here're are the key catalytic...

The American Society of Clinical Oncology's 2018 annual meeting is scheduled to be held in Chicago, Illinois June 1-5. In a Thursday note, JPMorgan evaluated the prospects for Dynavax Technologies Corporation (NASDAQ: DVAX) in the coming month, especially ahead of the ASCO presentations....

The American Society of Clinical Oncology, or ASCO, has scheduled its annual meeting on June 2–6, 2017, at McCormick Place, Chicago. The five-day event has Conquer Cancer Foundation as its lead sponsor. The event, typically attended by over 30,000, will be marked by presentations of...